Gameto, a biotechnology company focusing on women’s healthcare, has received recognition from Goldman Sachs for its CEO and Co-Founder, Dr. Dina Radenkovic, as one of the Most Exceptional Entrepreneurs of 2023. Dr. Radenkovic and the Gameto team are working on reproductive treatment solutions to modernize and improve the patient journey in fertility treatments. The company’s first product candidate, Fertilo, has shown promising results in maturing human eggs outside the body, potentially reducing the need for high-dose hormone injections and improving outcomes in IVF and egg freezing.
Goldman Sachs selected Dr. Radenkovic for this recognition at its Builders and Innovators Summit, where entrepreneurs from various industries are honored for their visionary work and market-redefining contributions. Dr. Radenkovic’s leadership in addressing the underdeveloped area of women’s health biotech, specifically in fertility treatments, is acknowledged as a significant contribution to the industry.
The recognition comes at a time when Gameto’s research, published in October 2023, demonstrates the effectiveness of Fertilo in maturing human eggs outside the body and creating healthy embryos. This breakthrough has the potential to revolutionize fertility treatments by reducing medical, financial, and emotional risks associated with traditional methods.
Dr. Radenkovic emphasizes the importance of modernizing the patient journey in fertility treatments, providing women with control over their fertility timeline. The acknowledgment from Goldman Sachs further highlights the significance of Gameto’s work in shaping the future of women’s healthcare and biotechnology.
